BRC Weekly BRC-ISSUE-2026-005 Vol. 1, No. 5
Pain That Exists Before the Test
Pain distribution and symptom burden can support a positive fibromyalgia judgment, but no single score or test establishes cause, truthfulness, or the patient’s whole condition. Eight articles connect criteria, measurement, daily change, clinical boundaries, and the next longitudinal study.
Editorial
From the editors
- Starting point
- The absence of a definitive biomarker does not mean that pain or functional impairment is absent.
- This issue’s finding
- Symptom criteria, sensory tests, and function questionnaires answer different questions; none independently establishes cause or whether pain is genuine.
- Next research step
- Track symptoms, sleep, activity, function, sensory testing, and treatment context on a person-level timeline without combining them into one score.
When fibromyalgia is discussed, the phrase “it does not show up on a test” is often made to do too much. This issue first separates the tools used to observe pain distribution, fatigue, waking unrefreshed, cognitive difficulty, and functional impact. An explicit symptom pattern can support a positive judgment without a definitive biomarker. Yet meeting criteria does not establish a particular pathophysiology, the absence of other illness, whether pain is genuine, or the whole condition of one person.
Source scope and edition limits
Measurements therefore cannot substitute for one another. When self-report, quantitative sensory testing, sleep records, and function questionnaires do not move together, the task is not to choose one as the “truth” but to preserve differences in observation window, test conditions, sample, and context. The next study should place symptom events, sleep, activity, seven-day function summaries, infrequent sensory tests, and treatment context on one timeline without collapsing them into one value.
Issue contents
Reading order
- 1 Read first
Critical synthesis
Pain That Exists Before the Test
A comparison of fibromyalgia criteria, QST, and FIQR explains how a positive clinical pattern can be identified without a definitive biomarker—and what it cannot establish.
- 2 Read next
Perspective
What the Absence of a Biomarker Does Not Mean
Learn what supports clinical judgment in fibromyalgia without a definitive biomarker, what that judgment cannot establish, and how to limit the meaning of a negative test.
- 3 Read next
Evidence map
The Evidence Landscape of Fibromyalgia
A comparison of fibromyalgia criteria, sleep measures, FIQR, and QST separates recurring evidence and group-level associations from unproven causation and individual mechanisms.
- 4 Read next
Methods paper
How Is Pain Measured?
A comparison of what WPI, SSS, pressure pain threshold, QST, and FIQR ask, when and how they measure it, and why they can classify the same patient differently.
- 5 Read next
Perspective
A Day Before Asking to Be Believed
A comparison of the time windows used by fibromyalgia criteria, sleep measures, FIQR, and QST separates what each records from the daily sequence none can establish.
- 6 Read next
Methods paper
Pain, Sensitization, Fatigue, and Functional Impairment
Distinguish the observations and measurement windows behind pain, fatigue, sensitization, and functional impairment in fibromyalgia, and the temporal evidence gap around post-activity worsening.
- 7 Read next
Counter-hypothesis
Is Central Sensitization an Explanation or a Conclusion?
Examine what central-sensitization and QST research can explain in fibromyalgia, and where protocol heterogeneity, individual diagnosis, and causal inference remain limited.
- 8 Read next
Research protocol
The Next Study That Tracks Symptoms and Function Together
A longitudinal fibromyalgia study design aligning symptom diaries, sleep, activity, FIQR function, QST, and treatment context with feasibility, prespecification, safety, and stopping rules.